发明名称 Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
摘要 Ivabradine (3-(3-(((7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-ylmethyl)methylamino)propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-bennzazepin-2-one) is used to prepare a medicament for treating endothelial dysfunction. ACTIVITY : Cardiant; Antilipemic; Antidiabetic; Hypotensive; Antiarteriosclerotic; Neuroprotective; Cerebroprotective; Nootropic. Rats with cardiac insufficiency were treated with (I) at a daily dose of 10 mg/kg for 3 months. This prevented endothelial dysfunction in the coronary, renal and cerebral arteries, the dilation of these arteries being similar to that of healthy animals. MECHANISM OF ACTION : None given.
申请公布号 ZA200800358(B) 申请公布日期 2008.11.26
申请号 ZA20080000358 申请日期 2008.01.11
申请人 LES LABORATOIRES SERVIER 发明人 BENATAR, VIDAL;LEREBOURS-PIGEONNIERE, GUY;TARDIF, JEAN-CLAUDE;THORIN, ERIC;RHEAUME, ERIC
分类号 A61K;C07C;C07D 主分类号 A61K
代理机构 代理人
主权项
地址